Home Newsfeeds Instil Bio Q3 EPS $(0.43) Down From $(0.33) YoY

Instil Bio Q3 EPS $(0.43) Down From $(0.33) YoY

Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.43) per share. This is a 30.3 percent decrease over losses of $(0.33) per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.43) per share. This is a 30.3 percent decrease over losses of $(0.33) per share from the same period last year.

Apple’s Timepiece Trouble: Patent Dispute Puts Apple Watch Imports in Jeopardy

By Benzinga Neuro

October 27, 6:29 AM

The U.S. International Trade Commission may ban the import of Apple Watches due to a patent infringement dispute with medical tech firm Masimo, pending a presidential review and potential appeals.

AAPL

Alnylam’s Lumasiran Scores Expanded FDA Approval For Ultra Rare Genetic Disease

By Vandana Singh

October 7, 10:56 AM

The FDA approved a label expansion for Alnylam Pharmaceuticals Inc’s (NASDAQ:ALNY) for Oxlumo (lumasiran), an RNAi therapeutic administered via subcutaneous injection, now…

ALNY

Absci Partners With Bioinformatics Company M2GEN To Accelerate Drug Creation For Oncology

By Happy Mohamed

April 4, 8:26 AM

Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, and M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomics data to accelerate discovery

ABSI